77.52
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $77.52, with a volume of 4.06M.
It is up +1.95% in the last 24 hours and up +14.05% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$76.04
Open:
$76.14
24h Volume:
4.06M
Relative Volume:
1.03
Market Cap:
$50.55B
Revenue:
$77.08B
Net Income/Loss:
$3.40B
P/E Ratio:
16.46
EPS:
4.711
Net Cash Flow:
$18.11B
1W Performance:
+4.28%
1M Performance:
+14.05%
6M Performance:
-5.02%
1Y Performance:
+6.62%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET vs MFC, AFL, PUK, PRU
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
77.52 | 49.58B | 77.08B | 3.40B | 18.11B | 4.711 |
|
MFC
Manulife Financial Corp
|
38.80 | 63.45B | 43.74B | 4.21B | 23.02B | 2.2184 |
|
AFL
Aflac Inc
|
112.98 | 57.67B | 17.16B | 3.65B | 2.56B | 6.8855 |
|
PUK
Prudential Plc Adr
|
30.84 | 38.72B | 27.81B | 4.12B | 1.87B | 3.07 |
|
PRU
Prudential Financial Inc
|
99.42 | 34.35B | 60.77B | 3.73B | 6.27B | 10.00 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-06-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
MetLife Supports Climate Innovation Through the Strauch Cleantec - GuruFocus
MetLife Supports Climate Innovation Through the Strauch Cleantech to Market Program, Advancing Sustainable Solutions - ACCESS Newswire
MetLife (MET) Issues Warning on Unsolicited Mini-Tender Offer - GuruFocus
MetLife warns shareholders against below-market mini-tender offer - Investing.com
MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited - The AI Journal
BofA Securities Adjusts MetLife Price Target to $99 From $103, Maintains Buy Rating - marketscreener.com
MetLife Inc. stock (US59156R1086): Why does its group-wide diversification now matter more for stabi - AD HOC NEWS
Third View Private Wealth LLC Invests $3.32 Million in MetLife, Inc. $MET - MarketBeat
Sumitomo Mitsui Trust Group Inc. Trims Stock Holdings in MetLife, Inc. $MET - MarketBeat
MetLife Inc stock (US59156R1086): Why dividend reliability matters more now for income investors - AD HOC NEWS
MetLife recently disclosed that the company has received an unsolicited mini-tender offer initiated by Potemkin. - Bitget
MetLife Inc. stock (US59156R1086): Why does its global reach matter more for U.S. investors now? - AD HOC NEWS
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
MetLife CEO Khalaf says there may be some cracks in private credit, but not a sign that it is a bubble about to burstSemafor event - marketscreener.com
Do Options Traders Know Something About MetLife Stock We Don't? - Yahoo Finance
MetLife unit MIM reported $26B in fixed income deals; AUM hit $144.7B - MSN
MetLife Foundation Awards Over $6.5 Million Globally to Address Essential Community Needs - ACCESS Newswire
TD Cowen Adjusts Price Target on MetLife to $87 From $88, Maintains Buy Rating - marketscreener.com
Moving Averages: Is MetLife Inc a momentum stockWall Street Watch & Smart Allocation Stock Tips - baoquankhu1.vn
UBS raises its price target on MetLife (MET) to $102 - MSN
How MetLife’s PineBridge Deal and Private Credit Push Could Reshape MET’s Investment Identity - Yahoo Finance
UBS Raises its Price Target on MetLife (MET) to $102 - Yahoo Finance
MetLife, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Metrics - Markets Mojo
Cantor Fitzgerald Investment Advisors L.P. Sells 30,901 Shares of MetLife, Inc. $MET - MarketBeat
MetLife (NYSE:MET) Stock Rating Upgraded by Wall Street Zen - MarketBeat
MetLife Inc. stock outperforms competitors despite losses on the day - MarketWatch
Today's Analyst Rating Data for MetLife (MET) | MET Stock News - GuruFocus
Wells Fargo & Company Has Lowered Expectations for MetLife (NYSE:MET) Stock Price - MarketBeat
MetLife Inc stock: UBS Buy rating and $102 target signal upside potential - AD HOC NEWS
Trilogy Capital Inc. Makes New Investment in MetLife, Inc. $MET - MarketBeat
MetLife (MET) Stock Forecast and Price Target 2026 $MET - MarketBeat
Evercore ISI Group Raises Target Price for MetLife (MET) to $96. - GuruFocus
MetLife Investment Management Originates $26 Billion in Private Fixed Income Deals - National Today
MetLife (MET) Expands AUM with $26B in Private Fixed Income Deals - GuruFocus
MetLife (MET) Boosts Private Fixed Income Portfolio - GuruFocus
UBS Adjusts Price Target on MetLife to $102 From $98, Maintains Buy Rating - marketscreener.com
Wells Fargo Adjusts Price Target on MetLife to $90 From $93, Maintains Overweight Rating - marketscreener.com
MetLife Investment Management Originates $26 Billion in Private Fixed Income Transactions in 2025 - The Joplin Globe
What to Expect From MetLife's Q1 2026 Earnings Report - Barchart.com
Jefferies Adjusts Price Target on MetLife to $92 From $96, Maintains Buy Rating - marketscreener.com
BMO Capital Adjusts Price Target on MetLife to $78 From $80, Maintains Market Perform Rating - marketscreener.com
Evercore ISI Adjusts Price Target on MetLife to $96 From $95, Maintains In Line Rating - marketscreener.com
MetLife Foundation Awards Grants to 26 Non-Profits in Asia As Part of Global Program Addressing Essential Community Needs - Yahoo Finance
MetLife (MET.PF) Stock Trends and Sentiment 2026 - MarketBeat
MetLife to Announce First Quarter 2026 Results - InsuranceNewsNet
MetLife Inc (MET) Stock Price Up 3.38% on Apr 8 - GuruFocus
MET: Barclays Adjusts Price Target but Maintains Overweight Rati - GuruFocus
Barclays Cuts MetLife (NYSE:MET) Price Target to $89.00 - MarketBeat
Fundamentals Check: Is MetLife Inc stock good for income investorsCPI Data & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Why Is MetLife, Inc. (MET) Stock Down Today? - Meyka
MetLife, Inc. $MET Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):